Market Analysts see Asensus Surgical Inc. [ASXC] gaining to $4. Time to buy?


Asensus Surgical Inc. [AMEX: ASXC] loss -5.55% on the last trading session, reaching $0.51 price per share at the time. The company report on April 20, 2022 that Investing in 60 Seconds: Asensus Surgical.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Asensus Surgical is leading the digital surgical market with Performance-Guided Surgery(TM).

New York, New York–(Newsfile Corp. – April 20, 2022) – PCG Digital — Surgery can be unpredictable, and a staggering one in five patients undergoing surgery has one, or even multiple, preventable surgical complications.

Asensus Surgical Inc. represents 234.94 million in outstanding shares, while the company has a total market value of $126.25 million with the latest information. ASXC stock price has been found in the range of $0.51 to $0.56.

If compared to the average trading volume of 2.88M shares, ASXC reached a trading volume of 3866297 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Asensus Surgical Inc. [ASXC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ASXC shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ASXC stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Asensus Surgical Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 26, 2021.

The Average True Range (ATR) for Asensus Surgical Inc. is set at 0.05, with the Price to Sales ratio for ASXC stock in the period of the last 12 months amounting to 15.40. The Price to Book ratio for the last quarter was 0.71, with the Price to Cash per share for the same quarter was set at 0.40.

Trading performance analysis for ASXC stock

Asensus Surgical Inc. [ASXC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.40. With this latest performance, ASXC shares dropped by -25.45% in over the last four-week period, additionally sinking by -72.31% over the last 6 months – not to mention a drop of -72.46% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASXC stock in for the last two-week period is set at 36.90, with the RSI for the last a single of trading hit 34.34, and the three-weeks RSI is set at 38.22 for Asensus Surgical Inc. [ASXC]. The present Moving Average for the last 50 days of trading for this stock 0.6413, while it was recorded at 0.5238 for the last single week of trading, and 1.4342 for the last 200 days.

Asensus Surgical Inc. [ASXC]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Asensus Surgical Inc. [ASXC] shares currently have an operating margin of -803.98 and a Gross Margin at -171.50. Asensus Surgical Inc.’s Net Margin is presently recorded at -758.77.

Return on Equity for this stock declined to -54.12, with Return on Assets sitting at -45.86.

Asensus Surgical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.60 and a Current Ratio set at 11.50.

An analysis of insider ownership at Asensus Surgical Inc. [ASXC]

There are presently around $37 million, or 33.00% of ASXC stock, in the hands of institutional investors. The top three institutional holders of ASXC stocks are: BLACKROCK INC. with ownership of 15,793,991, which is approximately 0.469% of the company’s market cap and around 0.70% of the total institutional ownership; STATE STREET CORP, holding 12,703,273 shares of the stock with an approximate value of $6.88 million in ASXC stocks shares; and VANGUARD GROUP INC, currently with $6.05 million in ASXC stock with ownership of nearly 0.698% of the company’s market capitalization.

Positions in Asensus Surgical Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 46 institutional holders increased their position in Asensus Surgical Inc. [AMEX:ASXC] by around 8,353,466 shares. Additionally, 49 investors decreased positions by around 2,118,910 shares, while 30 investors held positions by with 57,146,981 shares. The mentioned changes placed institutional holdings at 67,619,357 shares, according to the latest SEC report filing. ASXC stock had 17 new institutional investments in for a total of 2,479,844 shares, while 15 institutional investors sold positions of 323,585 shares during the same period.